Generic Name and Formulations:
Miconazole 50mg; buccal tablet.
Midatech Pharma US Inc.
Indications for ORAVIG:
Local treatment of oropharyngeal candidiasis.
Do not crush, chew, or swallow. Alternate application site. Apply to upper gum region, hold in place for 30 seconds to ensure adhesion. ≥16yrs: 50mg once daily in the AM for 14 consecutive days.
<16yrs: not recommended.
Allergy to milk protein concentrate.
History of hypersensitivity to azoles; monitor and discontinue if allergic reactions develop. Hepatic Impairment. Pregnancy (Cat.C). Nursing mothers.
May potentiate anticoagulant effects with warfarin (monitor PT, INR, evidence of bleeding). Caution with drugs metabolized by CYP2C9 and CYP3A4 (eg, oral hypoglycemics, phenytoin, ergot alkaloids).
Diarrhea, headache, nausea, dysgeusia, upper abdominal pain, vomiting, possible allergic reactions.
Clinical Pain Advisor Articles
- Risks Associated With Co-Administration of Aspirin and Other NSAIDs
- Stages of Low Back Pain Have Specific Sets of Clinical Indicators
- FDA Approves Aimovig for Migraine Prevention
- First Non-Opioid Drug Approved for Managing Opioid Withdrawal Symptoms
- Pain Interference Associated With Depression, Pain Self-Efficacy in Chronic Musculoskeletal Pain
- Effect of Prescription Drug Monitoring Programs on Fatal, Nonfatal Drug Overdoses
- Standardized SCS Workflow May Effectively Alleviate Failed Back Surgery Syndrome-Related Pain
- Marijuana Legalization and Opioid Prescribing Rates
- Medical Marijuana Users More Likely to Use Prescription Drugs for Medical, Nonmedical Purposes
- Interbrain Coupling During Handholding Associated With Analgesia, Empathy
- Remission Rates and Predictors of Chronic Headache
- Overuse and Underuse of Imaging Common in Low Back Pain Management
- Unit-Dose Packaging of Buprenorphine-Naloxone Effective on Unintentional Pediatric Exposure
- Language Used in Medical Record Can Affect Patient Care
- Opioid-Related Adverse Drug Events Associated With Worse Patient, Cost Outcomes